Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lloyd

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Clinical and Experimental Rheumatology|February 24, 2022
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case seriesVikram M K Joseph, Emily C Rose, Christopher J Edwards, et al.
Rheumatology (Oxford, England)|March 7, 2021
Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patientsIoana A Onac, Benjamin D Clarke, Cristina Tacu, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|February 27, 2021
An international study to develop the EAR-Q patient-reported outcome measure for children and young adults with ear conditionsAnne F Klassen, Charlene Rae, Neil W Bulstrode, et al.
Rheumatology Advances in Practice|April 2, 2026
Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohortJoseph Nathan, Bayram Farisogullari, Nicholas Jones, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Clinical and Experimental Rheumatology|February 24, 2022
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case seriesVikram M K Joseph, Emily C Rose, Christopher J Edwards, et al.
Rheumatology (Oxford, England)|March 7, 2021
Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patientsIoana A Onac, Benjamin D Clarke, Cristina Tacu, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|February 27, 2021
An international study to develop the EAR-Q patient-reported outcome measure for children and young adults with ear conditionsAnne F Klassen, Charlene Rae, Neil W Bulstrode, et al.
Rheumatology Advances in Practice|April 2, 2026
Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohortJoseph Nathan, Bayram Farisogullari, Nicholas Jones, et al.
Pageof 6